Skip to content

Neurotrope, Inc.: 10-Q filed 2015-08-14

What Neurotrope, Inc. reported in its quarterly report filed 2015-08-14 (fiscal Q2 2015): 24 published measures, 63 facts as tagged in accession 0001144204-15-049946.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-14
Fiscal period
fiscal Q2 2015
Accession
0001144204-15-049946 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Neurotrope, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-303,527,689USD
At 2014-12-318,161,048USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30-12,633,613USD
At 2014-12-31-11,652,303USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-303,390,238USD
At 2014-12-318,010,357USD
At 2014-06-3011,951,758USD
At 2013-12-3115,211,744USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-2,649,956USD91
2015-01-01 to 2015-06-30-5,016,225USD181
2014-04-01 to 2014-06-30-2,026,912USD91
2014-01-01 to 2014-06-30-3,717,409USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-3011,827USD181
2014-01-01 to 2014-06-300USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-23,298,914USD
At 2014-12-31-18,282,689USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-04-01 to 2015-06-300USD91
2015-01-01 to 2015-06-300USD181
2014-04-01 to 2014-06-300USD91
2014-01-01 to 2014-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-3062,396USD
At 2014-12-3153,618USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-06-30139,375USD91
2015-01-01 to 2015-06-30157,861USD181
2014-04-01 to 2014-06-3098,061USD91
2014-01-01 to 2014-06-30202,217USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2015-06-3018,281,973USD1003

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-303,465,293USD
At 2014-12-318,107,430USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-301,424,676USD
At 2014-12-311,289,188USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-30852,436USD
At 2014-12-31778,753USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,650,877USD91
2015-01-01 to 2015-06-305,018,714USD181
2014-04-01 to 2014-06-302,031,366USD91
2014-01-01 to 2014-06-303,726,292USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30586,821USD91
2015-01-01 to 2015-06-301,079,478USD181
2014-04-01 to 2014-06-30405,968USD91
2014-01-01 to 2014-06-30405,968USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3028,629,540shares
At 2014-12-3124,034,094shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3010,662,438USD
At 2014-12-316,627,983USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-06-3066,770USD
At 2014-12-3154,943USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-06-304,374USD
At 2014-12-311,325USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-30345,964USD
At 2014-12-31310,435USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-2,989,102USD91
2015-01-01 to 2015-06-30-5,690,790USD181
2014-04-01 to 2014-06-30-2,487,686USD91
2014-01-01 to 2014-06-30-4,625,619USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,237,982USD91
2015-01-01 to 2015-06-302,424,340USD181
2014-04-01 to 2014-06-301,021,464USD91
2014-01-01 to 2014-06-301,866,612USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-06-303,049USD181
2014-01-01 to 2014-06-300USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-3073,683USD181
2014-01-01 to 2014-06-30344,162USD181

Inspect the source

Entity
Neurotrope, Inc. / CIK 0001513856
Captured
SEC response SHA-256
e4116c454a6138c552b06ddd21a2c438e4d1f732828bc688d955a77a63d41b6b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001513856.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))